Hong-Wei Su

568 total citations
20 papers, 257 citations indexed

About

Hong-Wei Su is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Hong-Wei Su has authored 20 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Nephrology and 4 papers in Immunology. Recurrent topics in Hong-Wei Su's work include Tuberculosis Research and Epidemiology (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Hong-Wei Su is often cited by papers focused on Tuberculosis Research and Epidemiology (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Hong-Wei Su collaborates with scholars based in China, United States and Hong Kong. Hong-Wei Su's co-authors include Song Wu, Xu Zhang, Chong Li, Tao Tao, Xing Kang, Zhao Yang, Ruizhi Tan, Li Wang, Hangxing Ren and Wenzhong Liu and has published in prestigious journals such as Frontiers in Microbiology, Molecular Cancer and eLife.

In The Last Decade

Hong-Wei Su

16 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong-Wei Su China 7 194 136 28 18 15 20 257
Xiangyu Wang China 10 158 0.8× 50 0.4× 21 0.8× 18 1.0× 20 1.3× 33 291
Feng Hua China 10 181 0.9× 135 1.0× 50 1.8× 37 2.1× 15 1.0× 16 339
Mingxia Zhu China 11 277 1.4× 266 2.0× 22 0.8× 15 0.8× 28 1.9× 32 425
Ginu P. George India 9 247 1.3× 227 1.7× 27 1.0× 21 1.2× 13 0.9× 11 354
Xinting Pan China 11 214 1.1× 121 0.9× 22 0.8× 38 2.1× 60 4.0× 28 329
Ling Ji China 8 125 0.6× 54 0.4× 13 0.5× 21 1.2× 22 1.5× 14 221

Countries citing papers authored by Hong-Wei Su

Since Specialization
Citations

This map shows the geographic impact of Hong-Wei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong-Wei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong-Wei Su more than expected).

Fields of papers citing papers by Hong-Wei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong-Wei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong-Wei Su. The network helps show where Hong-Wei Su may publish in the future.

Co-authorship network of co-authors of Hong-Wei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Hong-Wei Su. A scholar is included among the top collaborators of Hong-Wei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong-Wei Su. Hong-Wei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Hong-Wei, Joshua D. Wallach, Yao Liu, et al.. (2025). A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicity. Nature Microbiology. 10(2). 468–481. 2 indexed citations
2.
Tan, Ruizhi, Lingfei Jia, Yibing Wang, et al.. (2025). Epigenetic regulation of macrophage function in kidney disease: New perspective on the interaction between epigenetics and immune modulation. Biomedicine & Pharmacotherapy. 183. 117842–117842. 3 indexed citations
3.
Gao, Jing, Pan Chen, Wenjing Zhao, et al.. (2025). Exosomes from renal cells and macrophages: Bidirectional communication in the pathogenesis of kidney disease. Cytokine. 192. 156961–156961.
4.
Xu, Linghui, Ruizhi Tan, Jing‐Yi Lin, et al.. (2025). Chaihuang Yishen Granule ameliorates mitochondrial homeostasis by upregulating PRDX5/TFAM axis to inhibit renal fibrosis in CKD. Phytomedicine. 139. 156426–156426. 3 indexed citations
5.
6.
7.
Li, Yuqing, Jing‐Yi Lin, Ruizhi Tan, et al.. (2024). Biochanin A suppresses Klf6-mediated Smad3 transcription to attenuate renal fibrosis in UUO mice. Phytomedicine. 135. 156067–156067. 5 indexed citations
8.
Wang, Yibing, Tong Li, Fengyu Wang, et al.. (2024). The Dual Role of Cellular Senescence in Macrophages: Unveiling the Hidden Driver of Age-Related Inflammation in Kidney Disease. International Journal of Biological Sciences. 21(2). 632–657. 6 indexed citations
9.
10.
Tan, Ruizhi, Lisa X. Xu, Tong Li, et al.. (2024). Serum untargeted metabolomics analysis of uremic pruritus in patients with various etiologies. International Immunopharmacology. 143(Pt 3). 113563–113563.
11.
Zhong, Xia, Yue Huang, Jian Liu, et al.. (2024). Astragalus mongholicus bunge and panax notoginseng formula (A&P) improves renal fibrosis in UUO mice via inhibiting the long non-coding RNA A330074K22Rik and downregulating ferroptosis signaling. BMC Complementary Medicine and Therapies. 24(1). 273–273. 3 indexed citations
12.
13.
Zhang, Hongmin, et al.. (2024). RfxCas13d-mediated inhibition of Circ1647 alleviates renal fibrosis via PI3K/AKT signaling pathway. Renal Failure. 46(1). 2331612–2331612. 5 indexed citations
14.
Jia, Jian, Linghui Xu, Chong Deng, et al.. (2023). Hederagenin ameliorates renal fibrosis in chronic kidney disease through blocking ISG15 regulated JAK/STAT signaling. International Immunopharmacology. 118. 110122–110122. 16 indexed citations
15.
Su, Hong-Wei, et al.. (2020). Forward Genetics Reveals a gatC-gatA Fusion Polypeptide Causes Mistranslation and Rifampicin Tolerance in Mycobacterium smegmatis. Frontiers in Microbiology. 11. 577756–577756. 5 indexed citations
16.
Su, Hong-Wei, Tao Tao, Zhao Yang, et al.. (2019). Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression. Molecular Cancer. 18(1). 27–27. 133 indexed citations
17.
18.
19.
Wei, Caihong, Li Li, Hong-Wei Su, et al.. (2014). Identification of the crucial molecular events during the large-scale myoblast fusion in sheep. Physiological Genomics. 46(12). 429–440. 3 indexed citations
20.
Ren, Hangxing, Hong-Wei Su, Lingyang Xu, et al.. (2011). Histological and transcriptome-wide level characteristics of fetal myofiber hyperplasia during the second half of gestation in Texel and Ujumqin sheep. BMC Genomics. 12(1). 411–411. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangyu Wang Breakdown of academic impact, for papers by Feng Hua Breakdown of academic impact, for papers by Mingxia Zhu Breakdown of academic impact, for papers by Ginu P. George Breakdown of academic impact, for papers by Xinting Pan Breakdown of academic impact, for papers by Ling Ji
Rankless by CCL
2026